Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Jaffa, Israel • RAPH (OQB)

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.

972 5 2775 5072 4 Lui Paster, Israel

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook - BioMarin Pharmaceutical
BioMarin Pharmaceutical • Dec 19
BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting - PR Newswire
PR Newswire • Sep 8
Cannabinoid-Based Formula Demonstrates Proof-of-Concept for Treating RA - HCPLive
HCPLive • Jan 8
Raphael Pharmaceutical Announces Positive Proof-of-Concept Clinical Study Results for the Company’s Cannabinoid-Based Formula for the Treatment of Rheumatoid Arthritis - Yahoo Finance
Yahoo Finance • Jan 7
Raphael Pharmaceutical Issues Letter to Shareholders - Cannabis Business Times
Cannabis Business Times • Jul 9

Other Drug Manufacturers - Specialty & Generic Companies

View All →
Elanco Animal Health Inc logo Elanco Animal Health Inc.
1 layoff tracked
$11.23B market cap
Zoetis Inc. logo Zoetis Inc.
$55.83B market cap
Galderma Group AG/ADR logo Galderma Group AG
$49.28B market cap
TAKEDA PHARMACEUTICAL CO LTD logo Takeda Pharmaceutical Co. Ltd.
$47.02B market cap
Haleon plc logo Haleon PLC
$44.93B market cap
TEVA PHARMACEUTICAL INDUSTRIES LTD logo TEVA Pharmaceutical Industries Ltd.
$32.82B market cap

Frequently Asked Questions

Has Raphael Pharmaceutical Inc. had layoffs?
No layoff events have been recorded for Raphael Pharmaceutical Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Raphael Pharmaceutical Inc. in?
Raphael Pharmaceutical Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Raphael Pharmaceutical Inc. a publicly traded company?
Yes, Raphael Pharmaceutical Inc. is publicly traded under the ticker symbol RAPH on the OQB. The company has a market capitalization of approximately $0.03 billion.
Where is Raphael Pharmaceutical Inc. headquartered?
Raphael Pharmaceutical Inc. is headquartered in Jaffa, Israel at 4 Lui Paster, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.